Q56.2
Female pseudohermaphroditism, not elsewhere classified
Clinical Classification Guidelines
Inclusion Terms
- Female pseudohermaphroditism NOS
Medical Intelligence & Overview
Female pseudohermaphroditism, classified under ICD-10 code Q56.2, is a condition where a person assigned female at birth has developing or developed physical characteristics typically associated with male genitalia. This condition is not classified elsewhere and is often diagnosed based on physical examination, hormonal testing, and genetic analysis. It's important to understand that this condition involves complex hormonal and developmental factors that can influence physical traits without affecting a person’s chromosomes or overall health. The term 'pseudohermaphroditism' indicates that the individual has ovaries and external genitalia that may be ambiguous or masculinized, but their ovaries are normally developed.
Causes & Symptoms
Clinical Causes: Congenital adrenal hyperplasia (a genetic disorder affecting hormone production) Androgen excess due to tumor or adrenal gland issues Exposure to androgenic substances during fetal development Genetic mutations affecting hormone receptors or enzymes involved in sex development Other hormonal imbalances occurring in utero
Key Symptoms: Ambiguous or masculinized external genitalia (such as enlarged clitoris or fused labia) Normal internal female reproductive organs (ovaries and uterus) Possibility of varying degrees of virilization depending on hormonal influence Sometimes, additional symptoms related to underlying hormonal imbalance or genetic conditions
Diagnostic & Treatment
Diagnosis Path: Physical examination to assess external genitalia and secondary sexual characteristics Hormonal tests measuring levels of androgens, estrogens, and other related hormones Genetic testing to identify chromosomal patterns and specific gene mutations Imaging studies such as ultrasound to examine internal reproductive organs Assessment of family history and any known genetic disorders
Treatment Protocols: Hormonal therapy to balance hormone levels and reduce virilization effects Surgical interventions to correct ambiguous genitalia or reconstructive procedures if desired Psychological support and counseling to address emotional and social aspects Management of any underlying endocrine or genetic disorders
Clinical Advice & FAQs
Billing Guidance
Is Q56.2 a billable ICD-10 code?
Yes, Q56.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q56.2?
Clinical documentation must specify the nature of Female pseudohermaphroditism, not elsewhere classified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference